IJTLD Open (ISSN: 3005-7590) is open access and fully compliant with Plan S.
The Journal primarily focuses on infectious diseases, including TB and non-tuberculous mycobacteria (NTM), alongside the role of risk factors and comorbidities. All open access research on chronic respiratory diseases is published in a sister title, IJTLD CRD.
IJTLD Open includes a broader range of article types than the traditional IJTLD, including: Editorials, Meeting reports; Original Articles (including methodology papers, qualitative research and operational research), State of the Art Reviews; Guidelines/Consensus documents; Systematic Reviews and Meta-Analysis; Viewpoints; Minireviews, Letters; Study Protocols; Case reports; Case series and Correspondence.
IJTLD OPEN is open access and free to read. Also, authors retain copyright and can freely distribute the PDF or upload it to any website. As a consequence, open access articles are highly downloaded and more highly cited.
Click the links below to read our content on PubMed Central, Ingenta.com or via links from the Directory of Open Access Journals (DOAJ), or PubMed. .
While preparing their article, authors should refer to the Instructions for Authors to check that they have complied with our requirements – see links below.
Once complete, authors should submit their manuscripts at http://mc.manuscriptcentral.com/ijtld
We invite authors with OA funding to submit their papers (including Editorials, Original Articles, Letters and Case Series) to IJTLD OPEN.
We welcome submissions on the development of vaccines, diagnostics and medicines for the prevention, management and control of TB and all other respiratory diseases.
This includes basic, translational, clinical, epidemiological and programmatic research relevant to the Union’s mission to find health solutions for these conditions.
For all queries please e-mail the Editorial Office
Sponsorship
Supplements and article series are a highly-effective way of highlighting a specific topic to researchers, clinicians and decision makers in respiratory health.
Being an Open Access journal, IJTLD OPEN has no barriers to access and can reach readers in health centres, medical, university and pharmaceutical institutes, along with civil society, patients and carers.
All content will be freely available on Ingenta.com and we will have regular mailings to highlight the latest sponsored content.
Fast-Track Articles
In order to share scientific research of immediate concern as rapidly as possible, The Union is fast-tracking the publication of certain accepted articles from the IJTLD, IJTLD OPEN and PHA and publishing them in full on our website, prior to their publication in the Journals. Read fast-track articles:
International Women's Day 2023: Prof Refiloe Masekela
On International Women’s Day 2023, we celebrate all of the inspirational women at The Union, as we stand for opportunities for all and…
International Women's Day 2023: Dr Olivia Mbitikon Dotar
On International Women’s Day 2023, we celebrate all of the inspirational women at The Union, as we stand for opportunities for all and…
The Union launches project to improve TB preventive treatment in Uganda
A research project has been launched to explore how tuberculosis (TB) preventive treatment can be improved for people living with HIV,…
Clinical internship improving MDR-TB knowledge sharing in Africa
As part of the Contribute to the Elimination of Tuberculosis in Africa (CETA) Project, a clinical internship programme was organised for…
Update on the Sub-Saharan Africa Regional Child and Adolescent TB Centre of Excellence
The Sub-Saharan Africa Regional Child and Adolescent TB Centre of Excellence (COE) is a virtual platform for sharing best practices,…
Treatment of Multidrug-Resistant Tuberculosis: The latest guidance from WHO
Treatment of multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) is difficult. Dr Chen-Yuan Chiang, Senior Consultant at The Union, discusses the World Health Organization's latest rapid communication.